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Abstract  
 
The CRIB family of small G protein effectors contain significant regions with 
intrinsic disorder. The G protein binding regions are contained within these 
intrinsically disordered regions. Most CRIB proteins also contain stretches of 
basic residues associated with their G protein binding regions. The basic 
region and G protein binding region together allow the CRIB effectors to bind 
to their cognate G protein via a dock and coalesce binding mechanism. The 
basic regions of these proteins take on multiple roles: steering G protein 
binding, interacting with elements of the membrane and regulating 
intramolecular regulatory interactions. The ability of these regions of the 
CRIBs to undergo multivalent interactions and mediate charge neutralizations 
equips them with all the properties required to drive liquid-liquid phase 
separation and therefore to initiate and drive signalosome formation. It is only 
recently that the structural plasticity in these proteins is being appreciated as 
the driving force for these vital cellular processes. 		
Abbreviations 
BR, basic region; CRIB, Cdc42/Rac interactive binding; GBD, G-
protein binding domain; GDP, guanosine-5'-diphosphate; GTP, 
guanosine-5'-triphosphate; IDR, intrinsically disordered region; IDP, 
intrinsically disordered protein; MoRE, Molecular Recognition 
Elements; MoRF, Molecular Recognition Feature. 		
Introduction 
 
The field of small G protein biology, as much as any other, has been 
dominated and beautifully informed by the structure-function paradigm. 
However, more recent re-evaluation has led to the emerging concept that 
many protein functions lie within intrinsically disordered regions (IDRs) of 
proteins, especially in signalling proteins (1-3). Signalling proteins are highly 
modular, often containing multiple, defined, structured domains, which are 
frequently linked by IDRs. IDRs have the ability to fold into one or more 
conformations or indeed to remain largely unstructured. This intrinsic disorder 
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often results in dynamic binding and allows for multiple partners. IDRs 
therefore play an important role in assembling subsets of components within 
signalosomes.	These properties have led to the realization that proteins with 
IDRs are often central hubs of signalling networks and are revealing a new 
disorder-function model. 
 
Disorder in the CRIB effectors  
 
A major group of Rho-family small G protein effectors consists of proteins 
containing a Cdc42/Rac interactive binding motif (CRIB)(4) As their name 
suggests, these are effector proteins for the Cdc42/Rac subfamily of Rho-
family proteins. The CRIB motif comprises eight conserved residues within a 
stretch of 16-18 amino acids (I-S-x-P-x(2,4)-F-x-H-x(2)-H-V-G)	and forms the 
consensus region of a larger G protein binding region (GBD). The CRIB motif 
itself is necessary but not sufficient for high affinity G protein binding and often 
has alternative roles in regulating the effector proteins themselves.  
 
The CRIB effector proteins fall into several functional protein families but are 
mainly protein kinases and/or actin regulatory proteins. This reflects the fact 
that despite the many roles carried out by the Rho-family small G proteins in 
cells, they are primarily known for their regulation of the actin cytoskeleton (5). 
Cdc42, Rac1 and RhoA constitute the archetypal trinity of Rho-family G 
proteins that control the formation of actin driven cellular structures such as 
filopodia, lamellipodia and stress fibres, crucially often signalling downstream 
of the master regulator small G protein, Ras. Many CRIB effector family 
proteins bind to both Cdc42 and Rac1 but a subset exclusively bind to Cdc42. 
Cdc42 induces the formation of filopodia by initiating actin remodeling, while 
Rac1 regulates lamellipodia development , with these structures being key to 
cell motility (5). 
 
Like the majority of small G proteins, Cdc42 and Rac1 act as molecular 
switches, which exist in two conformations. They are inactive when bound to 
GDP but become active when bound to GTP, changing conformation and 
becoming competent to bind immediate downstream effector proteins, such as 
the CRIB family. The switch mechanism itself is regulated by a series of 
proteins which act to turn the switch on or off in response to cellular stimuli. 
The switch is summarized in Figure 1, which also demonstrates the wealth of 
structural and biophysical data available for the complexes involved. 
Deregulation of these proteins is often associated with the progression of 
several disease states, including tumour metastasis (6). 
 
The CRIB family of small G protein effectors also falls into the category of 
proteins containing IDRs. Analysis of various CRIB proteins using disorder 
prediction software demonstrates significant stretches of disorder in these 
proteins and these contain the CRIB consensus sequences (Figure 2). In fact 
it would seem that the common use of the term G protein binding ‘domain’ is 
especially inappropriate for the CRIB effectors. Specifically, structural analysis 
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of the CRIB containing regions of these proteins, where available, suggests 
little, if any, native structure when unbound to partner proteins (7-9). 		
CRIB effector-Cdc42/Rac binding mechanism  
 
Along with the various informative structures available for the final complexes 
formed by CRIB effectors and their cognate small G proteins, an increasing 
amount of information pertaining to their mode of binding has emerged. It is 
becoming clear that the CRIB proteins adopt a ‘dock and coalesce’ 
mechanism, in line with many IDRs, when binding to small GTPases, with 
many likely using electrostatic steering in the initial docking phase. This 
mechanism involves coupled binding and folding, whereby the docking 
segment of the IDR establishes initial contact with its target, often through 
long range electrostatic interactions, followed by sections of the IDR binding to 
their target elements within the binding site on the partner protein in the 
coalescence phase to achieve the final stable complex.  
 
Steering 
For both disordered and ordered proteins, electrostatic attraction between the 
partners has been observed to drive enhanced binding rate constants (10). 
This has been well documented for Ras-effector protein complexes, where a 
two-step association has been observed experimentally and underpins the 
very high affinity of the complexes (11-14). In a similar manner, the function of 
a basic region (BR) N-terminal to the CRIB consensus has been extensively 
studied for (N-)WASP (Figures 3 and 4). Here, the BR has been shown to 
associate with negatively charged residues on Cdc42, positioning the N-
terminal CRIB consensus residues close to their binding site on Cdc42 (Figure 
4) and allowing the full CRIB and the remainder of the GBD to zip up with the 
switch regions of the GTPase, in a mutually stabilizing process ((15-17) and 
Tetley et al. under review). Our recent study indicated that residues in the BR 
closest to the CRIB residues have the largest contribution to binding (Tetley et 
al. under review). In addition, mutational studies on the BR show that a cloud 
of positive potential in this region is required for steering, rather than individual 
specific interactions ((15) and Tetley et al. under review). As this region of 
WASP lies within an IDR, the lack of structure potentially facilitates 
substitution between the residues, resulting in overall binding only being 
affected when all of the positive residues are removed. The available structure 
of WASP bound to Cdc42 (pdb 1CEE) does not include the residues in the BR 
that are more distal to the CRIB consensus but their juxtaposition to acidic 
residues in Cdc42 (including Glu181, which is likewise absent from the 
structure) means that they could also contribute to electrostatic interactions in 
the final complex (Figure 5C). 
 
As seen in Figure 3 most other CRIB effector proteins also contain an 
associated BR, N-terminal to the CRIB motif. Although little experimental 
analysis of these regions has been undertaken, computational analysis of the 
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role of the PAK1 BR suggests that it plays a similar role in electrostatic 
steering (17).  
 
From Figure 3 it is also apparent that ACK, unlike the other CRIB 
effectors, does not contain an obvious BR. However our work suggests 
that ACK also utilizes a dock and coalesce binding mechanism with the 
initial docking being mediated by the N-terminal region of the ACK 
GBD in a manner akin to the electrostatic steering or basic region 
docking demonstrated for Cdc42-WASP and postulated for Cdc42-
PAK, but differing significantly by being driven by hydrophobic contacts 
(Figure 5 and (18)). The patch of residues on ACK comprising Leu449, 
Ser450 and Ala451 contacts Cdc42 via residues in helix α5 and the C-
terminus of the G protein (e.g. Glu181). This hydrophobic patch 
interaction is further extended by Ile454ACK (see below), which contacts 
Leu177, Ile46, Gly47 and Gly48Cdc42, all of which are structurally stable. 
An intense concentration of hydrophobic potential is found on Cdc42, 
complementing the N-terminal hydrophobic residues of ACK and giving 
it plausible docking potential (18). This hydrophobic potential is also 
apparent in free Cdc42 in the GTP-bound form and so would be 
accessible to form an encounter complex (Figure 5).  
 
 
Coalescence 
Coalescence in IDRs can involve a second search for a new binding subsite, 
which is limited by the span of the tether between the dock and coalesce 
segments (19). This often slows the coalescence phase. However, for the 
CRIB effectors, it would seem likely that the proximity of the BR to the N-
terminus of the CRIB allows ‘guided’ coalescence due to the limited length of 
the tether, implying that coalescence should occur rapidly (almost 
immediately) after docking. This is supported by computational analysis (17). 
 
Our recent studies of the thermodynamic contribution of residues of the ACK 
and WASP GBDs to the complexes formed with Cdc42 indicate several 
residues that are key to binding and these are centred in both cases on the 
CRIB consensus residues. How the individual energetic contributions from 
these residues map onto the structures of the GBDs is shown in Figure 6. The 
GBDs are anchored to Cdc42 at each end by hydrophobic interactions. After 
steering, we envisage the hydrophobic contributions from the residues 
immediately C-terminal to the BR providing the anchor point for the interface, 
with the isoleucine of the CRIB consensus being the key residue.  
 
Complex formation between the CRIB effectors and Cdc42 takes an 
interesting twist at this point. For most IDRs studied, their target 
binding partner is a structured protein or structured domain. Although 
small G proteins are highly structured, the switch regions that bind 
effector proteins are flexible, changing conformation between the 
active and inactive forms of the proteins. For most small G proteins the 
switches are relatively mobile in the inactive, GDP-bound 
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conformation. In the active conformation, two states exist (state 1 and 
2)	with one or the other being more populated depending on the G 
protein. State 2 is the conformation capable of engaging effectors and 
is the dominant species in Ras when bound to a GTP analogue (20). 
For Cdc42 (the main target for CRIB effectors), on the contrary, the 
switches appear to be predominately in state 1 even when bound to a 
GTP analogue and only become stabilized in the state 2 conformation 
by the effector itself (21). The mechanism suggested to underpin this 
involves the effector initially binding loosely, creating a favourable 
hydrophobic cleft around Phe37Cdc42 and Val36 Cdc42. The resulting 
movement of switch I is then stabilized by Thr35 coordination to both 
the γ phosphate of GTP and to Mg2+. When GDP is bound this cannot 
occur and the effector complex is transitory; likewise without the 
effector protein, the active conformation is also transitory (21).  
 
Importantly, the CRIB consensus isoleucine binds to residues on Cdc42 
outside the flexible switch regions. This region of Cdc42 is not subject to the 
rearrangements experienced by the switches and provides a relatively stable 
platform to initiate the coalesce phase of complex formation and therefore 
facilitate molecular recognition for the two partners. For example, Ile454ACK 
contacts Leu177, Ile46, Gly47 and Gly48Cdc42 all of which are structurally 
stable, nucleotide independent residues. Similar contacts are seen between 
the equivalent CRIB consensus isoleucines in other complexes (9, 22). For 
both ACK and WASP, the first section of the GBD contains a concentration of 
residues that are energetically vital for binding (Figure 6).  
 
In the model of effector stabilization of state 2, CRIB effector residues in the 
vicinity of Phe37Cdc42 and Thr35Cdc42 will be of critical importance. These are 
engaged in the coalescence phase and reside in the more C-terminal sections 
of the GBDs ((18) and Tetley et al. under review). During the coalesce phase, 
it seems that the conserved histidines of the CRIB, assisted by other nearby 
residues, grasp switches I and II and create an environment where Thr35Cdc42 
can interact with both the γ phosphate of GTP and Mg2+ to create a stable 
complex. This drives further interactions through the CRIB region, completing 
the major part of coalescence, during which the CRIB residues in ACK and 
WASP (and presumably other CRIB effectors) position and stabilize the switch 
loops of Cdc42 in the active, state 2, conformation. The final stages of the 
coalesce phase would involve hydrophobic interactions with residues C-
terminal to the CRIB consensus, which act to stabilize and anchor the C-
terminal end of the interface ((18) and Tetley et al. under review). 
 
Thus, unlike many IDR interactions, where the target protein is structured, in 
the Cdc42-CRIB effector complexes the disordered structure of the effector 
and the conformational sampling of the target binding interface are together 
stabilized into the active signal transducing conformation by a reciprocal 
rigidifying mechanism, likely driven by favourable enthalpic contributions. A 
somewhat similar situation has previously been reported for Mcl-1-PUMA 
binding. The small, disordered protein PUMA folds into a helix when bound 
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into a groove on the surface of its ordered partner Mcl-1, however Mcl-1 is also 
observed to undergo conformational rearrangements, closing up around 
PUMA to stabilize the interaction (23). 
 
Functional Roles of CRIB IDRs in signalling 
 
WASP Activation in cells 
 
IDRs play important roles in assembling subsets of components in 
signalosomes, facilitating construction of reversible cellular assemblies. A 
good example of the involvement of a CRIB effector in these processes is that 
of the WASP proteins in actin polymerization. In WASP, the BR and GBD 
provide a dynamic binding region that is vital in determining the cellular 
sequelae of WASP interactions. The WASP proteins serve as platforms to 
integrate multiple signal inputs, with their activity controlled by numerous 
ligands and through multiple mechanisms with resulting WASP activation 
stimulating actin polymerization by Arp2/3 (24).  
 
Unstimulated WASP is autoinhibited, with the C-terminal, catalytic VCA region 
(named for its three sub-regions: verprolin (V) homology, central (C) 
hydrophobic and acidic (A) regions), bound by part of the GBD region (25). 
This interaction structures a region spanning residues His249 to Glu295, 
which includes the end of the CRIB consensus and the C-terminal region of 
the WASP GBD. The BR and N-terminal WASP GBD residues critical to 
Cdc42 binding, such as Ile233, Ile238, Pro241 and Phe244, are not within this 
structured region. However, the BR residues are thought to interact with the 
acidic region (A) of WASP/N-WASP (26, 27) due to complementary charge 
interactions. 
 
To stimulate actin polymerization, the VCA domain must interact with Arp2/3 
and so needs to be released from the GBD. The BR initiates this transition by 
interacting with the negative charge density on Cdc42. This weakens the 
structure of autoinhibited WASP and opens the N-terminal GBD residues for 
further interaction with Cdc42. The remaining WASP GBD residues can then 
exchange intramolecular interactions for contacts with Cdc42, releasing the 
VCA domain. Initial docking of Cdc42 and WASP relies on non-selective 
charge interactions, which could be achieved by WASP residues that are not 
involved in intramolecular interactions and therefore freely available. Hence, 
conformational sampling by the GBD, which is likely to be limited in the 
autoinhibited structure, would be unnecessary in this instance. 
 
PIP2 also plays a role in the activation of the WASP proteins, and N-WASP is 
synergistically activated by PIP2 and Cdc42 in vitro (28). N-WASP is 
multivalent for PIP2 binding (26), with multiple PIP2 molecules acting co-
operatively in WASP activation, in part because the BR of N-WASP appears 
again to be a constituent of the autoinhibition complex. Cdc42 significantly 
changes this co-operativity between N-WASP and PIP2, lowering the 
activation threshold and allowing lower levels of PIP2 to activate N-WASP. 
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Such observations imply that Cdc42 and PIP2 bind to N-WASP simultaneously 
to relieve VCA autoinhibition, the obvious mechanism being where Cdc42 
binds the GBD and some or all of the BR interacts with PIP2.  
 
Naturally this model, where PIP2 binds the BR, would aid membrane 
localization of N-WASP. PIP2 tends to be localized to certain areas of the 
membrane in nanoclusters (29) and considering that higher local densities of 
PIP2 activate N-WASP (Papayannopoulos, 2005 #1291), such sites could 
provide loci for actin nucleation, even in the absence of Cdc42. Membrane 
localization would however, also increase the chance of WASP encountering 
active Cdc42, which is similarly membrane localized, in the cell. The 
simultaneous binding of PIP2 and active, membrane localized, Cdc42 by 
WASP appears likely, particularly since the N-terminal region of the BR 
appears to be less important for Cdc42-WASP binding (Tetley et al. under 
review) leaving it available for PIP2 interaction. Since the interactions of the 
BR are electrostatic they are likely to be quite fluid and, as such, the residues 
of the BR could switch interactions between the acidic region of WASP, PIP2 
and Cdc42, aided by their intrinsic disorder.  
 
The on- and off-rates of WASP binding to Cdc42 are high ((15) Tetley et al. 
under review), and individual interactions with partners are likely to be 
simultaneously transient. However, the concurrent interaction of WASP with 
PIP2 and active Cdc42, facilitated by its disorder, could stabilize WASP in an 
open form by reducing the off-rate from the complex. Simultaneous binding at 
several linked sites is known to produce such an effect (30). The proximity of 
the BR and the GBD should strengthen the off-rate effect and reduce Cdc42-
WASP unbinding events. Stable release of the VCA should increase the 
duration and robustness of Arp2/3 activation.  
 
 
Other CRIB effectors 
 
Multiple roles for the disordered BR-CRIB regions are also seen in the PAK 
proteins. PAK1 also exists in an autoinhibited conformation and possesses a 
BR (Figure 3). Autoinhibited PAK1 has a structure very similar to that found in 
WASP, with the GBD and sequences immediately C-terminal folding to give a 
compact inhibitory switch (IS) domain (31). Unfortunately the BR is missing in 
these studies, however interaction with Cdc42 is postulated to initiate binding 
from the N-terminal region of the GBD (residues 70-84) and then proceed 
through the rest of the GBD, ultimately leading to unfolding of the IS domain 
and release of the kinase domain. The inclusion of the BR in this scheme 
would again serve to steer initial recognition using electrostatic interactions 
between the BR and Cdc42 as for WASP. In the absence of one of its binding 
partners, PAK1 70-149 is considered to be fully disordered (31), however 
NMR data for free 75-118 PAK show a helix from 101-108, which is 
maintained in the complexes formed with both Cdc42 and with the kinase (9, 
31). Structure is however obviously limited in the unbound form of the BR-
CRIB region of PAK1, as it is in WASP. 
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A more recent structure of full-length PAK4-Cdc42 also reports an interesting 
new potential function for the PAK4 BR (Figures 1 and 3).  In this structure, 
which is the first to report structural details for a full-length effector protein, 
Cdc42 is shown to make extra contacts to PAK4 outside the canonical GBD. 
Contacts are seen between helix α5 in Cdc42 and the kinase domain of PAK4 
and, in addition, the PAK4 BR sits in the substrate binding cleft of PAK4 in the 
presence of Cdc42, acting as an inhibitor in place of the displaced 
pseudosubstrate region (32). These data may explain why Cdc42 has not 
been seen to significantly activate the kinase activity of the type II PAKs (33, 
34); it seems rather that Cdc42 acts to prime PAK4 for full activation. If this 
complex were situated at a membrane, phospholipid interactions could also 
be present to engage the PAK4 BR and fully activate the complex.  
 
It seems likely that the presence of a BR juxtaposed to the CRIB region in 
these effectors correlates with the presence of an autoinhibited structure 
involving the GBD, where the BR can act as a vital motif in breaking up the 
native tertiary structure in the inactive proteins to ultimately allow GBD 
coalescence with Cdc42 and activation of the effector.  
 
Very little further data is available regarding the specific regulation of other 
CRIB effector proteins but all the available information points to the 
importance of the disorder of the GBD and its ability to interact with multiple 
partners/ligands.  
 
The MLKs (mixed-lineage kinases) are a subset of CRIB effectors, which 
belong to the MAP3K family and were the first group of serine/threonine 
kinases shown to be regulated by an intramolecular SH3-kinase interaction 
(35). For MLK3 the recognition site for the SH3 domain is a non-conventional 
single proline residue that resides lies very close to the BR (Figure 3). It is 
expected that binding of Cdc42 to the CRIB region disrupts the intramolecular 
SH3-proline interaction, activating the kinase activity.  
 
The CEP (BORG) family of CRIB effectors possess BRs and are also 
suspected to be subject to autoinhibition, in this case through the CII region 
(36). This family of CRIB effectors do not contain any domains of known 
biochemical activity and are therefore suggested to act structurally, possibly to 
scaffold interactions involved in regulation of the actin and septin networks.  	
As noted previously, ACK does not possess a BR (Figure 3) but is also not 
thought to be autoinhibited in a manner that involves the CRIB region (37), so 
that the ACK GBD is freely available to associate with Cdc42. The differences 
between the ACK GBD and the other CRIB effectors and their respective 
binding mechanisms with Cdc42 likely reflect evolutionary responses to the 
different roles of the GBDs in the complete effector proteins. 
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Potential role for disordered CRIB effectors in the formation of 
biomolecular condensates 
 
The unexpected revelation that P granules in C. elegans are actually liquid 
droplets with all the physical properties of classical liquids (38) and 
subsequent discoveries that their formation is driven by specific proteins with 
the capacity to separate from the surroundings by liquid-liquid demixing or 
phase separation (39), has opened up an entirely new view of cellular 
organization.  
 
It is now recognized that above a critical concentration certain types of 
proteins can drive phase separation, resulting in the creation of a protein-rich 
phase that is in equilibrium with the remaining protein-poor cytoplasm (or 
nucleoplasm). Even in the very early stages of research into cellular phase 
transitions it was noted that proteins with intrinsic conformational 
heterogeneity were in the driving seat (39). The membrane-less 
compartments, or biomolecular condensates, created by this phase 
separation act as cellular regions capable of facilitating biochemical reactions 
due to crowding.  These phase separated cellular ‘bodies’ impact on multiple 
cellular processes but are often centers for RNA processing, ribosomal 
biogenesis and stress responses (40). They are also involved in DNA-protein 
interactions e.g. at centrosomes and mitotic spindles (41). This process also 
seems particularly active in contributing to the organization of signalling 
complexes, with phase separated signalosomes existing at the membrane. In 
fact some of the best studied phase transition systems involve signalling 
complexes. Signalling from the T-cell receptor, resulting in actin remodeling is 
a particularly rich source of experimental evidence of phase-phase separation 
involvement in signal transduction (42). 
 
The Nephrin-Nck-N-WASP signalosome has also been used as a model 
system to understand the blossoming field of liquid-liquid phase transitions in 
cellular biology. In this system, interaction between the adhesion receptor 
Nephrin, the adapter Nck and the CRIB effector N-WASP results in phase 
separation of the signalling proteins into membrane associated puncta (43). 
The association of the proteins is mediated by multivalent interactions 
between the individual components as well as the presence of IDRs in the 
components, both of which are known to drive phase separation of proteins. 
Charge neutralization or electrostatic attraction is also a key process in phase 
separation (44) and the N-WASP basic region is implicated in this process, 
potentially aiding Nephrin phase separation by virtue of its positive charge 
(45). The presence of specific modular protein-protein interactions alongside 
non-specific charge interactions underpin the phase separation of the complex 
and lead to the formation of membrane puncta presumably representing the 
signalosome. A similar process has been observed in T-cell receptor 
signalling also involving N-WASP (42). 
 
As a variety of mechanisms exist to facilitate multivalent polymerization and 
phase separation, this process likely occurs in many signalling systems. Like 
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(N)WASP, many CRIB effectors contain both IDRs and charged regions, 
making them potential candidates to take part in or even drive these 
processes (Figures 2 and 3).  The small G protein direct regulators of the 
CRIB effectors are also likely participants in this procedure. Lipid anchored 
Ras has been shown to organize into dynamic clusters at the membrane, 
containing 6-8 Ras molecules (46). The formation of K-Ras nanoclusters has 
been elegantly demonstrated to ensure MAPK output from EGF stimulation is 
binary (47). Similarly Rac1, which binds a subset of CRIB effector proteins, 
has also been shown to form nanoclusters, which interestingly are larger 
(~200nm) and contain ~50 Rac1 molecules. The clusters are heterogeneous 
in terms of protein composition and include downstream effector proteins, 
which are then important for immobilizing Rac1 into the clusters (48). The 
recent observation of nanoclustered Cdc42, at least in yeast, suggests that 
this will be a general feature for small GTPases (49). The small GTPase 
nanoclusters may well constitute the marker for effector protein recruitment 
(and potentially further associated proteins) to the membrane, which, if the 
correct type of proteins are involved e.g. CRIB effectors, will then facilitate 
phase separation at the membrane and the formation of signalosomes. 
 
It appears, at least in the T-cell receptor system, that phosphatases may be 
excluded from the phase separated cluster while kinases (which are abundant 
in the CRIB family effectors) are enriched. Furthermore, phosphorylation by 
the kinases would be expected to enhance phase separation and therefore 
increase output from the signalosome in a positive feed-forward manner (42).  
 
 
Therapeutic possibilities: AttACKing IDRs 
 
80% of proteins involved in processes driving cancers contain IDRs (50) and 
60% of proteins associated with cardiovascular and neurodegenerative 
disorders can also be classified as IDPs	(51), so there is an increasing 
interest in IDRs as therapeutic targets. 
 
Most studies concentrate on screening for small molecules that bind the IDP 
and change its activity, for example by stabilizing their native disorder or 
inhibiting their interaction with partners. This approach has had some 
success, with several inhibitors of c-Myc/Max interaction identified that disrupt 
the c-Myc/Max interaction by binding to monomeric c-Myc and stabilizing 
conformations incompatible with Max heterodimerization (52). 	
An alternative strategy could involve using peptides based on the IDR itself to 
inhibit its interaction with partners. Peptide based therapeutic strategies have 
long been the poor relation of small molecule therapeutics, especially for 
intracellular targets. However, advances in stabilization and delivery have 
brought new hopes for this modality (53).  
 
IDPs mediate protein-protein interactions through a variety of elements. Short 
linear motifs (SLiMs) are generally between 3-10 amino acids and usually 
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exist in extended conformations in complex with their partners (54). Molecular 
recognition Elements (MoREs) or Molecular recognition features (MoRFs) are 
slightly longer sequences of 10-70 amino acids. These often undergo disorder 
to order transitions on binding and adopt thermodynamically stable, well-
defined structures in the context of the complex. When bound to their partner, 
MoRFs may form alpha-helices (α-MoRFs), beta-strands (β-MoRFs), irregular 
structure (i-MoRFs) or combinations of these elements (complex-MoRFs) 
(55). SLiMS and MoREs/MoRFs are therefore molecular recognition elements 
that capture the appropriate binding partner with high specificity. Therefore, as 
IDRs utilize various peptide motifs to mediate protein-protein interactions, they 
are a rich potential source of parent sequences for peptide therapeutics. 
 
One disadvantage of using the IDR itself as a starting point for a peptide 
therapeutic is that although IDPs bind their target with high specificity they 
tend to employ multivalent binding with each element having relatively low 
affinity for its partner. In fact the CRIB proteins, when binding to their cognate 
small G protein, go against this conventional paradigm, displaying high 
specificity with high affinity (low nM) mediated by a single site. With the luxury 
of both qualities, these CRIB effector IDRs are undoubtedly attractive as 
progenitor peptides. 
 
Our recent studies have dissected the kinetics and thermodynamics of the 
binding of both WASP and ACK GBDs to Cdc42 ((18) and Tetley et al. under 
review). WASP is the tighter binder of the two but removal of the WASP BR 
leaves ACK with the higher relative affinity. The corollary of this suggests that 
the ACK GBD with a BR would be expected to bind even more tightly, likely 
with picomolar affinity. Although this sequence may be too long to act as a 
therapeutic itself, it would provide an excellent starting point for further 
maturation. 
 	
Conclusions  
 
A model of Cdc42-CRIB effector binding involving a dock and coalesce 
mechanism initiated by electrostatic steering is evolving, where the 
interaction with the effector protein stabilizes switch I in the active 
conformation bringing the effector GBD and the flexible parts of Cdc42 
into a stable quaternary structure. Energetically important residues in 
the CRIB effectors are primarily concentrated in the N-terminus and 
CRIB consensus of the GBD. WASP and ACK bind initially to Cdc42 
via this N-terminal energetic hotspot where the complementary Cdc42 
structure is more rigid regardless of activation state and therefore 
provides a stable sub-site to initiate coalescence. In the case of 
WASP, PAK1 and likely the majority of CRIB effectors, this is assisted 
by a poly-lysine directed electrostatic steering mechanism, with the 
steering section playing little part in the final complex. In ACK, 
encounter would be directed by hydrophobic interactions that also 
remain as part of the final complex. 
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The electrostatic steering regions and GBDs of the CRIB effectors are 
also often involved in intramolecular regulation and take part in multiple 
interactions with a variety of partner proteins. The intrinsic disorder 
observed in the regions of the CRIB effectors that contain these 
binding elements equips them with important biophysical 
characteristics, the biological consequences of which are only just 
being revealed. The CRIB effectors are likely initiators of signalosome 
formation via multiple modular interactions with other components and 
play a key role in phase separation underpinned by charge interactions 
leading to final signalosome assembly. 
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Figure Legends 
 
Figure 1: The GTPase cycle of Cdc42: Cartoon representations are 
shown of Cdc42 in the GDP and GTP bound forms (pdb entries 1A4R 
and 2QR2 respectively). Cdc42 is shown as a cartoon in cyan and the 
nucleotide in a stick representation in red. Examples structures of 
Cdc42 in complex with its regulator are shown: Cdc42-Dbs (pdb entry 
1KZ7), the DH and PH domains from Dbs are shown in purple; Cdc42-
p50 RhoGAP (pdb entry 1AM4), the GAP domain of p50 RhoGAP is 
shown in green); Cdc42-RhoGDI1 (pdb entry 1DOA), RhoGDI1 is 
shown in pink and the geranyl geranyl group attached to Cdc42 is 
shown as a space fill in dark pink.  Cdc42-CRIB effectors complexes 
are shown wherever structures are available: Cdc42-WASP (pdb 
1CEE), the WASP GBD is in dark orange; Cdc42-ACK GBD (pdb 
1CF4), ACK is shown in yellow; Cdc42-PAK1 (pdb 1E0A), the PAK1 
GBD is shown in pale orange; Cdc42-PAK6 (pdb 2ODB), the PAK6 
GBD is shown in pale orange; Cdc42-PAK4 (pdb 5UPK), PAK4 is 
shown in pale orange. All other CRIB proteins in the family are listed 
for completion. The Kd of the Cdc42-WASP interaction is 1nM, Cdc42-
PAK1 is 20nM and Cdc42-ACK is 30nM as measured by scintillation 
proximity assays (56). The kon and koff rates for Cdc42-WASP are 
0.793 µM-1 s-1 and 19.9 ms-1 respectively. The kon and koff rates for 
Cdc42-ACK are 0.224 µM-1 s-1 and 27.8 ms-1 respectively as measured 
by biolayer interferometry (18). 
 
 
Figure 2: Disorder prediction plots for selected CRIB effector 
proteins: Protein sequences were submitted to the Genesilico 
MetaDisorder Service for analysis (57). Predictions for both ACK and 
MRCKα were performed in two halves due to the residue limit of the 
predictions. For clarity 4 plots, corresponding to predictions from the 
final metapredictions are shown: MetaDisorder (blue), MetaDisorder3D 
(black), MetaDisorderMD (green) and MetaDisorderMD2 (orange). 
Protein sequences submitted for analysis were as follows: ACK 
(Q07912), WASP (P42768), N-WASP (O00401), PAK1 (Q13153), 
CEP1 (Q00587), SPEC1 (Q9NRR8), MLK2 (Q02779) and MRCKα 
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(Q5VT25). The position of the first conserved Ile of the CRIB 
consensus sequence for each protein is indicated by a red asterisk. 
 
Figure 3: Alignment of the CRIB consenus residues of CRIB effector 
proteins and their basic regions. Uniprot accession numbers for all proteins 
are shown, as are the residue ranges. Basic residues preceding the CRIB 
consensus are highlighted in red. The SH3 recognition proline in MLK3 is 
highlighted in green. 
 
Figure 4: Model of the dock and coalesce binding mechanism of Cdc42-
WASP. The model shows the van der Waals surface of Cdc42 in the Cdc42-
WASP structure (pdb entry 1CEE) as a solid in grey, with acidic residues (Asp 
and Glu) coloured pink. Residues Glu49 and Glu178 (which are involved in 
electrostatic WASP docking) are coloured red. The WASP GBD is shown as a 
cartoon coloured green, with the BR coloured blue. The final panel is rotated 
~45° to display more of the elements of the final complex. 
 
Figure 5: Docking regions of Cdc42-ACK and Cdc42-WASP. (A) Van der 
Waals surface of the Cdc42-ACK structure (pdb entry 1CF4). The van der 
Waals surface of Cdc42 is solid and shown in grey, with hydrophobic residues 
(Ala, Gly, Val, Ile, Leu, Phe and Met) coloured orange. ACK residues 448-489 
are shown as a blue mesh. (B) As in A, but with ACK removed to show the 
hydrophobic potential of Cdc42 in the ACK binding site. (C) Van der Waals 
surface of Cdc42-WASP structure (pdb entry 1CEE). The van der Waals 
surface of Cdc42 is again solid and shown in grey, with acidic residues (Asp 
and Glu) coloured pink. Residues Glu49 and Glu178 (which are involved in 
electrostatic WASP docking) are coloured red. Potential electrostatic 
interactions from residues not contained in the structure are indicated as 
cartoon representations where positively charged residues are coloured blue 
and negatively charged residues are red. The relevant residues are also 
labelled. (D) As in C, but with WASP removed to show the negatively charged 
residues of Cdc42 around the WASP docking site. 
 
Figure 6: Energetic contributions of ACK and WASP GBD residues to 
Cdc42 complex formation. (A) The van der Waals surface of WASP 
residues 225-275 as a grey mesh with the protein backbone in black. The 
structure of WASP shown is the conformation it adopts when in complex with 
Cdc42 ((22) and pdb entry 1CEE). Residues involved in interaction with 
Cdc42 are coloured with respect to the fold-change in Kd upon mutation to 
alanine as follows: green for 5-15-fold increase, yellow for 15-40-fold increase, 
orange for 40-100-fold increase, red for a >100-fold increase. The amino acid 
sequence for this region is shown below the structural representation, with 
residues coloured in the same manner and with font size also indicating 
relative energetic contribution to complex formation. Accession number for 
WASP: P42768. (B) The van der Waals surface of ACK residues 448-489 as 
a grey mesh with the protein backbone in black. The structure of ACK shown 
is the conformation it adopts when in complex with Cdc42 ((8) and pdb entry 
1CF4). Residues involved in interaction with Cdc42 are coloured as in A. The 
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amino acid sequence for this region is shown below the structural 
representation, with residues coloured as in A. Accession number for ACK: 
Q07912.  
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